Inhibition of the interaction of age-rage prevents hyperglycemia-induced fibrosis of the peritoneal membrane

Journal of the American Society of Nephrology

Volumn 14, Issue 8, 2003, Pages 2109-2118

  De Vriese, An S ^a,d   Flyvbjerg, Allan ^b   Mortier, Siska ^a   Tilton, Ronald G ^c   Lameire, Norbert H ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c University of Texas Medical Branch School of Medicine   (United States)

^d General Hospital St Jan   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALBUMIN; FIBRONECTIN; FRUCTOSAMINE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; NONHUMAN; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; ULTRAFILTRATION; URINARY EXCRETION;

EID: 0041342000     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. De Vriese AS, Mortier S, Lameire NH: What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int 21 [Suppl 3]: S9-S18, 2001
2. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT: Peritoneal Biopsy Study Group. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479, 2002
3. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Kubo H, Shigematsu T, Sakai O, Horiuchi S: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51:182-186, 1997
4. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S: Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration, Nephrol Dial Transplant 14: 1541-1549, 1999
5. Park MS, Lee HA, Chu WS, Yang DH, Hwang SD: Peritoneal accumulation of AGE and peritoneal membrane permeability. Perit Dial Int 20: 452-460, 2000
6. Schmidt AM, Yan SD, Wautier JL, Stern D: Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84: 489-497, 1999
7. Boulanger E, Wautier MP, Wautier JL, Boval B, Panis Y, Wernert N, Danze PM, Dequiedt P: AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression. Kidney Int 61: 148-156, 2002
8. Margetts PJ, Kolb M, Yu L, Hoff CM, Holmes CJ, Anthony DC, Gauldie J: Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 160: 2285-2294, 2002
9. De Vriese AS, Tilton RG, Stephan CC, Lameire N: Diabetes-induced microvascular proliferation and hyperpermeability in the peritoneum: role of vascular endothelial growth factor. J Am Soc Nephrol 12: 1734-1741, 2001
10. Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, Brock TA, Williamson JR: Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 99: 2192-2202, 1997
11. Bjercke RJ, Cook G, Rychlik N, Gjika HB, Vunakis HV, Langone JJ: Stereospecific monoclonal antibodies to nicotine and cotinine and their use in enzyme-linked immunosorbent assays. J Immunol Meth 90: 203-213, 1986
12. Yeh CH, Sturgis L, Haidacher J, Zhang XN, Sherwood SJ, Bjercke RJ, Juhasz O, Crow MT, Tilton RG, Denner L: Requirement of p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes 50: 1495-1504, 2001
13. Shirakawa F, Saito K, Bonagura CA, Galson DL, Fenton MJ, Webb AC, Auron PE: The human prointerleukin-1-β gene requires DNA sequences both proximal and distal to the transcription start site for tissue-specific induction. Mol Cell Biol 13: 1332-1344, 1993
14. Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harris AG, Orskov H: Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion. Kidney Int 41: 805-812, 1992
15. Garred LJ, Canaud B, Farrell PC: A simple kinetic model for assessing peritoneal mass transfer in chronic ambulatory peritoneal dialysis. ASAIO J 6: 131-137, 1983
16. Rippe B, Stelin G, Haraldsson B: Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 40: 315-325, 1991
17. Greten J, Kreis I, Wiesel K, Stier E, Schmidt AM, Stern DM, Ritz E, Waldherr R, Nawroth PP: Receptors for advanced glycation end-products (AGE) expression by endothelial cells in non-diabetic uraemic patients. Nephrol Dial Transplant 11: 786-790, 1996
18. Kreisberg JI, Garoni JA, Radnik R, Ayo SH: High glucose and TGF-β1 stimulate fibronectin gene expression through a cAMP response element. Kidney Int 46: 1019-1024, 1994
19. Throckmorton DC, Brogden AP, Min B, Rasmussen H, Kashgarian M: PDGF and TGF-β mediate collagen production by mesangial cells exposed to advanced glycosylation end products. Kidney Int 48: 111-117, 1995
20. Tada H, Isogai S: The fibronectin production is increased by thrombospondin via activation of TGF-β in cultured human mesangial cells. Nephron 79: 38-43, 1998
21. Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP: Glycated albumin stimulates fibronectin gene expression in glomerular mesangial cells: involvement of the transforming growth factor-beta system. Kidney Int 53: 631-638, 1998
22. Oh JH, Ha H, Yu MR, Lee HB: Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int 54: 1872-1878, 1998
23. Sakata N, Meng J, Takebayashi S: Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb 7: 169-176, 2000
24. Isono M, Chen S, Won Hong S, Carmen Iglesias-de la Cruz M, Ziyadeh F: Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 296: 1356, 2002
25. Ha H, Yu MR, Lee HB: High glucose-induced PKC activation mediates TGF-β1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59: 463-470, 2001
26. Medcalf JF, Walls J, Pawluczyk IZ, Harris KP: Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): the role of TGF-β. Nephrol Dial Transplant 16: 1885-1892, 2001
27. Yung S, Liu ZH, Lai KN, Li LS, Chan TM: Emodin ameliorates glucose-induced morphologic abnormalities and synthesis of transforming growth factor betal and fibronectin by human peritoneal mesothelial cells. Perit Dial Int 21[Suppl 3]: S41-S47, 2001
28. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108: 1853-1863, 2001
29. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP: Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101: 1219-1224, 1998
30. Hirata C, Nakano K, Nakamura N, Kitagawa Y, Shigeta H, Hasegawa G, Ogata M, Ikeda T, Sawa H, Nakamura K, Ienaga K, Obayashi H, Kondo M: Advanced glycation end products induce expression of vascular endothelial growth factor by retinal Muller cells. Biochem Biophys Res Commun 236: 712-715, 1997
31. Murata T, Nagai R, Ishibashi T, Inomuta H, Ikeda K, Horiuchi S: The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 40: 764-769, 1997
32. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T: Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 61: 570-578, 2002
33. Yamagishi S, Yonekura H, Yamamoto Y, Katsuno K, Sato F, Mita I, Ooka H, Satozawa N, Kawakami T, Nomura M, Yamamoto H: Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem 272: 8723-8730, 1997
34. Kuroki M, Voest EE, Amano S, Beerepoot LV, Takashima S, Tolentino M, Kim RY, Rohan RM, Colby KA, Yeo KT, Adamis AP: reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo. J Clin Invest 98: 1667-1675, 1996
35. Williams B, Gallacher B, Patel H, Orme C: Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46: 1497-1503, 1997
36. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, Gauldie J: Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13: 721-728, 2002